Evidence map›Paper›PMID 35235127›Full record

ArticleThe Psychiatric quarterly2022

Profiles of Patients with Opioid Use Disorders Presenting a History of Suicidal Ideations and Attempts.

Léonie Archambault, Didier Jutras-Aswad, El Hadj Touré, Ana Carolina Artunduaga, Stéphane Roy, David Barbeau, Michel Perreault

Abstract read
PubMed Publisher
In one paragraph

Article in The Psychiatric quarterly, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Léonie ArchambaultSherbrooke University, Sherbrooke, QC, Canada.ORCID http://orcid.org/0000-0002-8980-3664
Didier Jutras-AswadCentre hospitalier de l'Université de Montréal Research Center, Montréal, QC, Canada.
El Hadj TouréSherbrooke University, Sherbrooke, QC, Canada.
Ana Carolina ArtunduagaDouglas Research Center, 6875 Boulevard Lasalle, Montreal, QC, H4H 1R3, Canada.
Stéphane RoyCIUSSS du Centre-Sud-de-L'île-de-Montréal, Montreal, QC, Canada.
David BarbeauCIUSSS du Centre-Sud-de-L'île-de-Montréal, Montreal, QC, Canada.
Michel PerreaultDouglas Research Center, 6875 Boulevard Lasalle, Montreal, QC, H4H 1R3, Canada. Michel.Perreault@douglas.mcgill.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Suicide rates are higher for people with an opioid use disorder, compared to the general population. This study aims to characterize opioid agonist treatment entrants who present a history of suicidal ideations or suicide attempts, according to concurrent comorbidity profiles, in an opioid use disorder treatment facility. A chart review design was used. Data was collected from 202 patient files. Bivariate and multivariate analyses were conducted. In multivariate analysis, patients with a diagnosis or symptoms of a mood disorder were 2.48 [1.01 - 6.11] times more likely to report suicidal ideations and 2.64 [1.05 - 6.62] times more likely to report suicide attempts. Those with a diagnosis or symptoms of an anxiety disorder were 2.41 [1.01 - 5.81] times more likely to report suicidal ideations. Patients who report chronic pain were 2.59 [1.06 - 6.35] times more likely to report suicidal ideations as well. The probability to report suicide attempts was 5.09 [1.16 - 22.4] times higher for those with a confirmed or suspected personality disorder. Clinicians should bear in mind the high suicide rates in people with opioid use disorder, as well as the importance of addressing suicidal risk and providing easy access to mental health and chronic pain treatment as part of the service offer in opioid agonist treatment. Future research should focus on evaluating the effectiveness of treatments aimed at addressing the needs of opioid agonist treatment patients with interrelated mental health and pain comorbidity profiles to reduce risks associated with suicide.

Indexed as

Chronic PainOpioid-Related DisordersAnalgesics, OpioidHumansRisk FactorsSuicidal IdeationSuicide, AttemptedAnalgesics, OpioidComorbiditiesOpioid agonist treatmentOpioid use disorderSuicidal ideationsSuicide attempts

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.